EFM
VRDN icon

E Fund Management’s Viridian Therapeutics VRDN Stock Holding History

E Fund Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349K Buy
+17,847
New +$530K 0.01% 356
2025
Q1 		– Sell
-12,236
Closed -$235K – 435
2024
Q4 		$235K Buy
+12,236
New +$266K 0.01% 345
2024
Q2 		– Sell
-19,323
Closed -$338K – 382
2024
Q1 		$338K Buy
19,323
+8,448
+78% +$164K 0.02% 259
2023
Q4 		$237K Sell
10,875
-2,562
-19% -$40.4K 0.02% 258
2023
Q3 		$206K Buy
13,437
+315
+2% +$6.01K 0.02% 255
2023
Q2 		$312K Buy
13,122
+3,078
+31% +$79K 0.02% 214
2023
Q1 		$256K Buy
+10,044
New +$322K 0.02% 260

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return